oasis 1 trial oral semaglutide 50 mg obesity nejm 2023 FDA approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy ( semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the A newly approved 7.2-mg dose

doi: 10.1016/j.neuron.2022.10.020 269 PapeK.TamouzaR.LeboyerM.ZippF

The next wave of GLP-1s: Pipeline and market expansion Recent FDA approvals have expanded indications for cardiovascular risk reduction, sleep apnea and chronic kidney disease

CD4 + CD25 + T regulatory cells (Tregs) are a subpopulation of T-cells [156] that mediate anti-inflammatory effects by suppressing pro-inflammatory T-cell responses and promoting M2 macrophage polarization

Be sure to talk to your doctor for sound advice before starting any weight loss program and understand it will take time and discipline for permanent results

Additionally, these injections are known to have extra benefits apart from making ones skin whiter such as immunomodulation and detoxification among others